Saif, M Wasif <br/><br/>
Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Dec 2005 
 - 8679-87 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2005.02.0628  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--genetics<br/>Aged<br/>Antimetabolites, Antineoplastic--adverse effects<br/>Capecitabine<br/>Combined Modality Therapy<br/>Deoxycytidine--adverse effects<br/>Dihydrouracil Dehydrogenase (NADP)--genetics<br/>Dose-Response Relationship, Drug<br/>Dose-Response Relationship, Radiation<br/>Female<br/>Fluorouracil--analogs & derivatives<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Hematologic Diseases--etiology<br/>Humans<br/>Male<br/>Middle Aged<br/>Pancreatic Neoplasms--genetics<br/>Radiotherapy, Adjuvant--adverse effects<br/>Statistics as Topic<br/>Survival Analysis<br/>Thymidine Phosphorylase--genetics<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--genetics